What is NAB Dutaxel 100 mg?

NAB Dutaxel 100 mg is an anticancer medicine containing paclitaxel formulated as protein-bound particles. It belongs to a group of chemotherapy medicines known as taxanes or microtubule inhibitors. The product is supplied as a sterile, lyophilized powder in a single-dose vial and is intended for intravenous administration by trained healthcare professionals.

Samarth Life Sciences lists NAB Dutaxel as paclitaxel protein-bound particles for injectable suspension, 100 mg, supplied as one vial.

Paclitaxel works by interfering with structures called microtubules inside cells. These structures are important during cell division. By stabilizing microtubules and preventing their normal breakdown, paclitaxel interferes with the ability of rapidly dividing cancer cells to reproduce. This makes it useful as part of chemotherapy treatment for certain cancers.

Albumin-bound paclitaxel is different from conventional solvent-containing paclitaxel formulations. The active medicine is associated with albumin, a naturally occurring protein, and the formulation does not contain the same solvent system used in some conventional paclitaxel products.

NAB Dutaxel is a prescription oncology medicine and is not intended for self-treatment. Its selection, preparation, administration, and monitoring should be performed by an appropriately qualified healthcare team.

Uses of NAB Dutaxel 100 mg

Paclitaxel protein-bound particles are used in the treatment of certain cancers. Depending on the patient’s cancer type and treatment plan, it may be used alone or together with other anticancer medicines.

Medically established uses of albumin-bound paclitaxel include:

• Metastatic breast cancer in specific treatment settings.
• Locally advanced or metastatic non-small cell lung cancer (NSCLC), where it may be used in combination with carboplatin.
• Metastatic adenocarcinoma of the pancreas, where it may be used in combination with gemcitabine.

The exact treatment plan depends on factors such as the type and stage of cancer, previous treatments, blood-cell counts, liver function, overall health, and other medicines being used.

NAB Dutaxel should only be administered under the supervision of a qualified oncologist or healthcare professional.

Benefits of NAB Dutaxel 100 mg

NAB Dutaxel is used as part of cancer treatment rather than as a general medicine for symptom relief. Its potential clinical benefits are related to its ability to interfere with the growth and division of cancer cells.

Potential treatment benefits include:

• Helps slow or inhibit the growth of susceptible cancer cells.
• Can form part of chemotherapy treatment for certain advanced cancers.
• May be used as a single chemotherapy component or alongside other anticancer medicines, depending on the cancer.
• Provides an albumin-bound formulation of paclitaxel for intravenous oncology treatment.
• Can contribute to disease-control strategies when selected as appropriate by an oncology specialist.

The response to treatment varies considerably between patients. NAB Dutaxel should not be described as a guaranteed cure, and treatment decisions must be individualized by the treating cancer specialist.

How Does NAB Dutaxel Work?

The active ingredient in NAB Dutaxel is paclitaxel. Cancer cells often divide more rapidly than many normal cells. Cell division requires microtubules, which are dynamic structures that help cells organize and separate their genetic material.

Paclitaxel binds to microtubules and promotes their stabilization. This prevents the normal reorganization of microtubules required for cell division. As a result, susceptible cancer cells can become unable to complete normal cell division and may subsequently die.

In NAB Dutaxel, paclitaxel is formulated as albumin-bound particles. The formulation is supplied as a sterile lyophilized powder that is prepared for intravenous infusion by healthcare professionals.

Because the formulation and administration requirements differ from other paclitaxel products, albumin-bound paclitaxel should not be substituted with or treated as interchangeable with conventional paclitaxel formulations.

How is NAB Dutaxel Administered?

NAB Dutaxel is not a medicine that patients administer themselves. The product shown on the package is specifically labeled for intravenous infusion.

A qualified healthcare team prepares and administers the medicine according to the patient’s individualized oncology treatment plan. The treatment schedule and amount are determined by the treating specialist and can be modified depending on blood counts, side effects, liver function, cancer type, and other clinical factors.

Patients should never attempt to prepare, inject, or adjust this medicine themselves.

NAB Dutaxel 100 mg Side Effects

Like all medicines, NAB Dutaxel may cause side effects, although not everyone experiences them.

Common Side Effects

Possible adverse effects associated with albumin-bound paclitaxel include:

• Reduced white blood cell counts
• Reduced red blood cell counts
• Low platelet counts
• Hair loss
• Tiredness or weakness
• Nausea
• Vomiting
• Diarrhea
• Reduced appetite
• Muscle or joint pain
• Peripheral sensory neuropathy, which may cause numbness, tingling, or altered sensation
• Injection-site or infusion-related reactions

The likelihood and severity of side effects can depend on the treatment regimen and whether other chemotherapy medicines are administered at the same time.

Serious Side Effects

Some reactions can be medically serious and require urgent attention. These include:

• Severe reduction in blood-cell counts, which can increase the risk of infection or bleeding.
• Severe or worsening numbness, tingling, or other nerve-related symptoms.
• Serious hypersensitivity or allergic reactions.
• Severe infection or sepsis.
• Lung inflammation or pneumonitis.
• Significant liver-related problems.
• Serious skin or other systemic reactions.

Severe myelosuppression is an important warning associated with albumin-bound paclitaxel, and blood counts need to be monitored during treatment.

If a patient develops severe symptoms during or after chemotherapy, the treating medical team should be contacted promptly.

Warnings and Precautions

NAB Dutaxel requires careful medical supervision.

Blood Counts

Paclitaxel protein-bound particles can cause significant suppression of bone marrow activity, resulting in reduced blood-cell counts. Healthcare professionals generally monitor complete blood counts during treatment.

Liver Problems

The medicine requires particular caution in patients with impaired liver function. Depending on the severity of hepatic impairment and the cancer being treated, treatment may require modification or may not be appropriate.

Neuropathy

Peripheral neuropathy can occur with paclitaxel treatment. Patients should tell their oncology team about persistent numbness, tingling, burning sensations, or other changes in sensation.

Pregnancy

Paclitaxel can cause fetal harm. Patients who are pregnant, planning pregnancy, or who could become pregnant should discuss the treatment with their healthcare professional before therapy.

Breastfeeding

Breastfeeding decisions should be discussed with the treating physician because paclitaxel therapy may pose a risk to a breastfeeding infant.

Allergies

Patients should inform their medical team about previous allergic or hypersensitivity reactions to paclitaxel, albumin, or any component of the formulation.

Other Medical Conditions

Tell the oncology team about liver disease, kidney problems, previous chemotherapy reactions, nerve problems, infections, or other significant health conditions before treatment.

Drug Interactions

NAB Dutaxel can interact with other medicines or treatments. Patients should provide their healthcare team with a complete list of:

• Prescription medicines
• Over-the-counter medicines
• Vitamins
• Herbal products
• Nutritional supplements
• Other cancer treatments

Paclitaxel is metabolized through several enzyme pathways, and other medicines may affect its exposure or toxicity. The prescribing team should therefore review the patient’s complete medication history before treatment.

Patients should not start, stop, or change another medicine during chemotherapy without discussing it with their healthcare professional.

Storage Instructions

NAB Dutaxel is a sterile injectable oncology product intended for handling by healthcare professionals.

General storage and handling requirements should follow the manufacturer’s approved product information and institutional oncology procedures. Keep the product in its original packaging and protect it from inappropriate environmental conditions.

• Keep out of reach of children.
• Do not use the product after its expiry date.
• Do not use a vial if the packaging is damaged or the product appears unsuitable.
• Preparation and disposal should be performed according to appropriate cytotoxic-drug handling procedures.

Because preparation requirements can vary by product and manufacturer, healthcare professionals should consult the approved product information before preparation or administration.

NAB Dutaxel 100 mg Price

The price of NAB Dutaxel 100 mg can vary depending on the supplier, location, applicable taxes, hospital or pharmacy charges, and other factors. Because this is a prescription oncology medicine, availability and pricing should be confirmed through an authorized healthcare or pharmaceutical channel.

Price should not be the only consideration when selecting a cancer medicine. Patients should confirm the exact product, strength, manufacturer, packaging, and prescription requirements with their healthcare provider or pharmacist.

NAB Dutaxel 100 mg Manufacturer

According to the manufacturer’s product information, NAB Dutaxel is a product of Samarth Life Sciences Pvt. Ltd. and is listed under its Conquest division. The manufacturer’s product listing identifies it as paclitaxel protein-bound particles for injectable suspension, with a strength of 100 mg and packing of one vial.

Frequently Asked Questions

1. What is NAB Dutaxel 100 mg used for?

NAB Dutaxel contains albumin-bound paclitaxel and is used as part of chemotherapy for certain cancers. Established uses of albumin-bound paclitaxel include specific treatment settings involving metastatic breast cancer, non-small cell lung cancer, and metastatic pancreatic adenocarcinoma.

2. How does NAB Dutaxel work?

Its active ingredient, paclitaxel, interferes with microtubules that cancer cells need for cell division. By stabilizing these structures and disrupting normal cell division, paclitaxel can inhibit the growth of susceptible cancer cells.

3. Is NAB Dutaxel safe?

NAB Dutaxel can be an appropriate chemotherapy medicine when prescribed for a suitable patient and administered with appropriate monitoring. However, it can cause significant adverse effects, including low blood-cell counts and nerve problems. Safety depends on individual health factors and medical supervision.

4. Can NAB Dutaxel be used long term?

The duration of treatment is determined by the treating oncologist. It depends on the cancer type, response to treatment, laboratory results, side effects, and the overall treatment plan. Patients should not continue, stop, or alter chemotherapy independently.

5. What happens if a scheduled treatment is missed?

NAB Dutaxel is administered by a healthcare team, so patients should contact their oncology clinic if they cannot attend a scheduled treatment. The healthcare professional will decide how the treatment schedule should be adjusted.

6. Can NAB Dutaxel be stopped suddenly?

NAB Dutaxel is chemotherapy rather than a medicine that patients normally stop independently. Any decision to delay, discontinue, or modify treatment should be made by the treating oncologist after considering the patient’s cancer status and treatment-related effects.

7. Can NAB Dutaxel be taken with food?

NAB Dutaxel is an intravenous medicine, not an oral tablet or capsule. Food therefore does not determine how the medicine is taken. Patients should follow their oncology team’s instructions regarding eating, drinking, and preparation for each treatment visit.

8. What are the common NAB Dutaxel side effects?

Common adverse effects can include reduced blood-cell counts, tiredness, hair loss, nausea, gastrointestinal symptoms, muscle or joint discomfort, and peripheral neuropathy. The exact effects differ between patients and may also depend on other medicines used during chemotherapy.

9. Who should avoid or use caution with NAB Dutaxel?

Treatment may not be appropriate in certain patients, including those with specific blood-count abnormalities or serious hypersensitivity to the medicine. Significant liver impairment may also affect treatment decisions. The prescribing oncologist should assess the patient’s medical history and laboratory results before treatment.

10. How should NAB Dutaxel be stored?

NAB Dutaxel should be stored and handled according to the manufacturer’s approved instructions and healthcare-facility procedures. It is a sterile cytotoxic injectable product, so preparation, administration, storage, and disposal should be managed by trained healthcare professionals.

Important Disclaimer

This product description is provided for general educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. NAB Dutaxel 100 mg is a prescription chemotherapy medicine and should only be used when prescribed and administered under appropriate medical supervision.

Do not self-medicate, attempt to administer the injection yourself, or change a chemotherapy treatment schedule without guidance from a qualified healthcare professional. Individual responses to treatment vary, and the risks and benefits must be assessed for each patient.

For complete prescribing information, healthcare professionals should refer to the applicable approved product information. The FDA prescribing information for albumin-bound paclitaxel identifies important risks including severe myelosuppression, neuropathy, hypersensitivity reactions, infection/sepsis, pneumonitis, and embryo-fetal toxicity.